A Study to Evaluate the Progression of Gastrointestinal and Fatigue Symptoms in the Scleroderma Population Seen at Mayo Clinic Arizona


About this study

The purpose of this study is to evaluate the progression of gastrointestinal and fatigue symptoms over time (approximately 5 years) in the scleroderma population seen at Mayo Clinic Arizona.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria 

  • Adult
  • Has scleroderma 
  • Has previously completed the questionnaire packet

Exclusion Criteria

  • None

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Sarah Umar, M.D.

Contact us for the latest status

Contact information:

Michael Crowell Ph.D.

(480) 301-6990


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer